Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Type I interferons play a key role in the development of various skin diseases.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Not having enough cystatin M/E protein causes less hair growth and dry skin.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Researchers found four genes that could help diagnose severe alopecia areata early.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Targeting NETs may help reduce fibrosis in Crohn's disease.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.